+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030- Product Image
Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030- Product Image
New

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032582
Description Jump to:
The global celiac disease treatment market size was valued at USD 582.5 million in 2023 and is projected to grow at a CAGR of 11.8% from 2024 to 2030. This growth is attributed to the increasing prevalence of diagnosed cases, which has heightened the demand for effective treatments and diagnostic methods. In addition, growing public awareness regarding celiac disease symptoms and the importance of early diagnosis has led to more individuals seeking medical attention. Furthermore, the expanding gluten-free food industry supports the market by providing diverse dietary options. Advances in diagnostic technologies and ongoing research into new treatment modalities further contribute to market growth by improving the detection and management of the disease.

Governments of many nations are implementing various initiatives to create awareness about celiac disease and uplift the accessibility to diagnostics and treatment for every individual. For instance, some countries have conducted screening programs specifically targeting high-risk populations. In addition, point-of-care testing (POCT) for celiac disease has gained acceptance in the past few years because of its quick diagnostic proficiencies. This allows for timely diagnosis and enables early treatment, avoiding further severe risks to the patient. Along with increased disease awareness, key companies invest in drugs and gluten-free products to enhance patients' health and overall outcomes. The benefits of gluten-free products have led to the adoption and utilization of gluten-free items.

Furthermore, the market for celiac disease treatment is anticipated to expand worldwide, fueled by the development of anti-inflammatory drugs and therapeutic vaccines, rising healthcare expenditure, and continuous medical research, which further contribute to market growth. Adopting therapeutic products and rising diabetes cases in several countries is expected to surge market growth. In addition, R&D activities and expenditure for innovative treatment alternatives and practices executed by various healthcare organizations have opened more opportunities for market expansion of celiac disease treatment.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global celiac disease treatment market report based on treatment, route of administration, distribution channel, and region:

Treatment Outlook (Revenue, USD Million, 2018 - 2030)

  • Vitamins & Minerals
  • Gluten-free Diet
  • Medical Therapies
  • Infliximab
  • Larazotide Acetate
  • Azathioprine
  • Budesonide
  • Others

Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

  • Oral
  • Parenteral

Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Research Centers
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Celiac Disease Treatment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Celiac Disease Treatment Market: Treatment Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Celiac Disease Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
4.3. Vitamins and Minerals
4.3.1. Vitamins and Minerals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Gluten-free Diet
4.4.1. Gluten-free Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Medical Therapies
4.5.1. Medical Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.1. Infliximab
4.5.1.1.1. Infliximab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.2. Larazotide Acetate
4.5.1.2.1. Larazotide Acetate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.3. Azathioprine
4.5.1.3.1. Azathioprine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.4. Budesonide
4.5.1.4.1. Budesonide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.5. Others
4.5.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Celiac Disease Treatment Market: Route of Administration Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Celiac Disease Treatment Market: Route of Distribution Movement Analysis, 2023 & 2030 (USD Million)
5.3. Oral
5.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Parenteral
5.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Celiac Disease Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Celiac Disease Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital
6.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Centers
6.4.1. Research Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis
7.1. Celiac Disease Treatment Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Teva Pharmaceutical Industries Ltd.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Amgen Inc.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Amneal Pharmaceuticals LLC.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Glenmark Life Sciences Limited
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Takeda Pharmaceutical Company Limited.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Hikma Pharmaceuticals PLC
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Viatris Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Zydus Pharmaceuticals, Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Novartis AG
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. BioLineRx Ltd.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
Table 4 North America Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 5 North America Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 North America Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 U.S. Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 8 U.S. Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 9 U.S. Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 Canada Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 11 Canada Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 12 Canada Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Mexico Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 14 Mexico Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 15 Mexico Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
Table 17 Europe Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 18 Europe Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 Europe Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 UK Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 21 UK Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 UK Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Germany Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 24 Germany Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 25 Germany Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 France Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 27 France Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 28 France Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Spain Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 30 Spain Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 Spain Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 33 Italy Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 Italy Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Denmark Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 36 Denmark Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 37 Denmark Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Sweden Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 39 Sweden Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 Sweden Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Norway Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 42 Norway Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Norway Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 49 Japan Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
Table 50 Japan Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 China Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 52 China Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 53 China Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 54 India Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 55 India Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 56 India Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 South Korea Celiac Disease Market, By Treatment 2018 - 2030 (USD Million)
Table 58 South Korea Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
Table 59 South Korea Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Australia Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 61 Australia Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 62 Australia Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Thailand Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 64 Thailand Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 65 Thailand Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Latin America Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
Table 67 Latin America Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 68 Latin America Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 69 Latin America Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Brazil Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 71 Brazil Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
Table 72 Brazil Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Argentina Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 74 Argentina Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 Argentina Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 South Africa Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 81 South Africa Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 South Africa Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 86 UAE Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 87 UAE Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 88 UAE Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 89 Kuwait Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
Table 90 Kuwait Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Kuwait Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research approaches
Fig. 2 Value chain-based sizing & forecasting
Fig. 3 Market formulation & validation
Fig. 4 Celiac Disease market segmentation
Fig. 5 Market driver analysis (current & future impact)
Fig. 6 Market restraint analysis (current & future impact)
Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 8 Porter’s five forces analysis
Fig. 9 Celiac Disease market: Treatment outlook and key takeaways
Fig. 10 Celiac Disease market: Treatment movement analysis
Fig. 11 Vitamins & Minerals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 12 Gluten-free Diet market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Medical Therapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Infliximab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Larazotide Acetate market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Azathioprine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Budesonide market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Celiac Disease market: Route of administration outlook and key takeaways
Fig. 20 Celiac Disease market: Route of administration movement analysis
Fig. 21 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Celiac Disease market: Distribution channel outlook and key takeaways
Fig. 24 Celiac Disease market: Distribution channel movement analysis
Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Research Centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 North America Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Canada Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mexico Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 UK Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Germany Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 France Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Italy Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Spain Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Denmark Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Sweden Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Norway Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Japan Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 China Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 India Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Australia Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Thailand Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 South Korea Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Latin America Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Brazil Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Argentina Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 MEA Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Africa Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UAE Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Kuwait Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 List of key emerging company’s/disruptors/innovators

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • Amneal Pharmaceuticals LLC.
  • Glenmark Life Sciences Limited
  • Takeda Pharmaceutical Company Limited.
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Zydus Pharmaceuticals, Inc.
  • Novartis AG
  • BioLineRx Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Celiac Disease Drugs Market by Drug, Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Celiac Disease Drugs Market by Drug, Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Global Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region - Product Image

Global Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region

  • Report
  • Global
From
Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2024 - Product Image

Celiac Disease - Pipeline Insight, 2024

  • Clinical Trials
  • 115 Pages
  • Global
From
Celiac Diseases Drugs Market 2024-2028 - Product Image

Celiac Diseases Drugs Market 2024-2028

  • Report
  • 162 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.